Summary
Advanced practice nursing in the United States is a fast-growing, workforce-driven part of primary and specialty care. The Bureau of Labor Statistics projects nurse practitioner employment to rise from 336,300 jobs to 474,100 jobs 1, and the HRSA workforce analysis reports 38.5% growth in NP numbers over its reported period 3. Most NPs work in physician offices (47%) and hospitals (25%) 5. Peer-reviewed studies link state full practice authority to more NP primary care visits and less non-urgent emergency department use 6, but readmission and mortality results depend on whether care transitions are included 8, and several difference-in-difference estimates are not significant 7. Principal risks are unsettled outcome evidence, missing data on cost, payment and digital health, and shortage pressure, including a projected 11% RN shortage in nonmetro areas 3. Outlook: demand for NPs is projected to keep rising, but stakeholders need comparable cost, quality and access data before drawing firm conclusions about where advanced practice care delivers the most value.
Key findings
-
1
Nurse practitioner employment is projected to grow strongly
BLS projects NP employment to rise from 336,300 to 474,100 jobs, with NPs the fastest-growing occupation in the projection set. These are forecasts, not observed counts.
Confidence: High -
2
NP numbers have grown while LPN numbers have fallen
The HRSA analysis reports NP numbers up 38.5% over its reported period while LPN numbers declined 6.0%. The exact start year is not stated in the excerpt.
Confidence: High -
3
Full practice authority is linked to more primary care visits and less non-urgent emergency use
A state-level national study found a modest but significant rise in NP primary care visits without a corresponding decline in physician visits, and lower non-urgent emergency department use in full practice authority states. The study period is not stated in the excerpt.
Confidence: Medium -
4
Outcome effects of NP scope depend on care transitions
Full authority with transition showed lower 30-day readmission odds (0.91) versus restricted practice, while full authority without transition showed higher in-hospital mortality odds (1.11). The study covers Medicare beneficiaries.
Confidence: Medium -
5
The global nursing shortage is large but projected to narrow
The global nursing workforce grew from 27.9 million to 29.8 million, and the shortage is estimated at 5.8 million, projected to fall to 4.1 million in a later period. The projection is a forecast.
Confidence: High -
6
Nursing shortages are treated as a health emergency by the nursing association
The International Council of Nurses calls the worldwide nurse shortage a global health emergency and says many countries have not invested enough in nurse education, leading to reliance on international recruitment. This is an advocacy position, not a measured estimate.
Confidence: Qualitative
1Industry definition and scope
This report covers advanced practice nursing, which the Bureau of Labor Statistics groups as nurse anesthetists, nurse midwives and nurse practitioners 1. Nurse practitioners are the largest and fastest-growing part of this group in the projections reviewed here 12. The American Association of Colleges of Nursing describes APRNs as nurses prepared in master's and doctoral programs 4.
The report uses two geographic scopes. Workforce projections, employment settings and regulation evidence are United States data. Nursing workforce shortage figures are global 9. The two scopes are not combined into a single market size.
Key terms: RN means registered nurse; LPN means licensed practical nurse; APRN means advanced practice registered nurse; NP means nurse practitioner. Full practice authority (FPA) is used only as the cited studies use it, to compare states that grant NPs FPA with restricted states 678. The pack does not restate the statutory definition, so this report does not define it further.
The report describes industry patterns and evidence. It is not individual medical, legal, investment or engineering advice.
Scope follows the source pack. Latest available data are used; no year is reported because the pack gives placeholder periods for most figures.
2Market size, structure and value chain
The pack contains no verified market revenue or market size for advanced practice nursing services, so this report does not estimate one. Workforce scale is the best available indicator: more than four million RNs, LPNs and APRNs were in the US workforce 3. The RN workforce is anticipated to grow from 3.46 million to 3.66 million, an increase of 166,100 nurses 4. The two figures are rounded and do not reconcile exactly, so the increase should be read as the source's stated figure.
Employment settings show where NPs currently practice. Of NPs, 47% work in physician offices, 25% in hospitals and 9% in outpatient centers 5. The remaining share is not given in the pack. This split is the most recent setting data retrieved, and it may not reflect current distribution.
The value chain as evidenced in the pack runs from education to employment. Master's and doctoral programs prepare APRNs, and about 32,700 new APRNs a year are needed for primary and specialty care demand 4. Employers include physician offices and hospitals 5. The pack does not verify payer mix, reimbursement rates or revenue models for NP services.
Interpretation: the growth in NP headcount is a staffing signal, not a revenue measure. The BLS figure of about 32,200 openings a year 1 and the AACN figure of about 32,700 new APRNs needed each year 4 use different definitions, so they should not be added or substituted for each other.
- Projected nurse practitioner employment 474,100jobs Forecast United States, Projected, latest BLS projection period [1]
- Nurses in the US workforce (RNs, LPNs and APRNs, minimum) 4,000,000nurses Observed United States, Latest available [3]
Market size is not estimated because no verified revenue or spending figure is in the pack.
Assumptions behind these figures
- Setting shares are treated as a snapshot of the latest available split and are not assumed to be current.
3Customers, demand and adoption
The BLS links demand for NPs to two main drivers: increased healthcare demand from newly insured patients and aging Baby Boomers 5. These are cited as demand context for the projections, so they describe why demand is expected to rise rather than measured utilization.
Projected growth is strong. BLS projects employment of nurse anesthetists, nurse midwives and nurse practitioners to grow 36% over the projection period 1. For NPs alone, reporting on the same BLS data gives 41% growth, an estimated gain of about 137,800 jobs 2. Both are forecasts. The 41% figure is consistent with the BLS NP counts of 336,300 and 474,100 jobs 1, which imply a gain of 137,800 jobs.
Access and supply are the main barriers evidenced. The HRSA analysis projects a 3% national RN shortage and an 11% shortage in nonmetro areas 3. Where RN supply is thin, advanced practice roles may carry more of the primary care load, but the pack does not test this link.
The pack does not verify purchasing criteria for employers, payers or patients, nor patient satisfaction, wait times or adoption rates for NP services. Demand for NP care is therefore described through workforce projections and employment patterns only.
- Projected RN shortage nationally 3percent Forecast United States, Projected, latest available [3]
Demand is inferred from workforce projections and cited drivers, not from observed service volumes.
Assumptions behind these figures
- The nonmetro shortage figure applies to rural and nonmetropolitan areas as defined in the HRSA source, which the pack does not restate.
4Competitive landscape and key players
The pack does not name competing companies, provider groups or market shares for NP services, so no company-level competitive comparison is possible. Representative provider types are the physician office, hospital and outpatient center settings in which NPs work 5. The source does not report their relative size, revenue or market share.
A fair comparison of public, private and community providers is not possible from the pack. The evidence is national or state-level and does not compare sectors. The pack also lacks waiting-time, quality and cost comparisons across these provider types for advanced practice nursing.
Competitive pressure in the pack comes mainly from state scope-of-practice rules. States with full practice authority differ from restricted states in NP primary care visits 6, non-urgent emergency use 6 and readmission rates 78. Where NPs may practice independently, the state regulatory setting shapes which providers can compete for primary care demand.
Business models and differentiation are not verified. The pack gives no evidence on pricing, payer contracts or market concentration, so this report draws no conclusion on concentration or competitive intensity.
No company names or share data appear in the source pack; none are added.
5Technology, operations and workforce
The pack contains no verified data on digital health adoption, including telehealth or AI tools, for NP care. Technology adoption is therefore unsupported and is not assessed. Established practice (NPs working in physician offices and hospitals 5) can be distinguished from emerging policy-driven practice (independent NP practice under full practice authority 67), but the pack gives no adoption data for the second category.
Workforce growth is the strongest evidenced trend. NP numbers grew 38.5% in the HRSA period, while LPN numbers fell 6.0% 3. The pattern suggests a shift toward advanced practice roles within the nursing workforce, though the source does not explain the cause.
Talent supply depends on education. Master's and doctoral programs produce APRNs 4, and the AACN estimates about 32,700 new APRNs a year are needed for primary and specialty care demand 4. The pack does not report program capacity, enrollment or graduation numbers, so the gap between need and supply cannot be measured here.
Productivity, staffing ratios and operating cost effects are not verified. The report does not estimate them.
- Growth in nurse practitioner numbers 38.5percent Observed United States, Reported period in HRSA analysis (start year not stated) [3]
Workforce trends are reported from HRSA and AACN figures; operational productivity is not inferred.
6Regulation, standards, risk and sustainability
The jurisdiction that matters most in the pack is the United States, and specifically the states. Full practice authority is a state-level scope-of-practice condition, and the cited peer-reviewed studies compare FPA states with restricted states 678. The pack does not identify the specific statutes, rules or effective dates, so the report cannot separate binding requirements in each state from proposals or voluntary guidance.
No federal rule, professional standard or international regulation for NP practice is cited in the pack. Standards for outcome evidence are therefore set by the study designs. The FPA studies show mixed results: most FPA-by-post coefficients in one analysis were not statistically significant 7, and the outcome effects in another depended on whether a care transition was included 8.
Safety is an evidenced risk area. In the Medicare population, full authority without transition showed higher in-hospital mortality odds (1.11) than restricted practice 8. This is a population-level finding, not guidance for any individual patient or clinical decision.
Privacy, data protection, environmental and social sustainability factors are not covered by the pack. Equity by race, rurality or income for NP access was not verified beyond the nonmetro RN shortage projection 3. These gaps are material for any regulatory assessment and are reported as unknown.
Regulatory status is reported only as the pack describes it. No legal conclusion is drawn.
Assumptions behind these figures
- Scope-of-practice differences are treated as state-level policy variation, not as a single national rule.
7Challenges, opportunities and case examples
The pack contains no verified company case studies. Comparable company or provider examples were limited, so the examples here are the cited studies and organizations. The most direct comparison is between states with and without full practice authority, as examined in the national state-level study 6, the diabetes and asthma readmission study 7 and the transition-of-care outcomes study by authors at the University of Texas Medical Branch and Wright State University 8.
The opportunity evidenced is better primary care access. The national study found more NP primary care visits and less non-urgent emergency department use in FPA states 6. This is a potential benefit for systems with ED crowding, but the pack does not measure ED crowding or waiting times.
The main constraint is that outcome effects are small or inconsistent. Diabetes-related readmission rate ratios were modestly lower (0.97) in FPA states 7, and most coefficients lacked significance in the same analysis 7. Shortage pressure is a further constraint, with nonmetro RN shortages projected to reach 11% 3.
Global context adds urgency. The ICN describes the nurse shortage as a global health emergency 10, and the global shortage is estimated at 5.8 million, projected to fall to 4.1 million 9. The narrowing is a forecast and depends on investment 10.
| Study and measure | Result reported | Evidence type and limits |
|---|---|---|
| S6: NP primary care visits | Modest but significant rise, with no corresponding decline in physician visits | Observed, state-level national analysis; study period not stated |
| S6: non-urgent emergency department use | Decreased in FPA states | Observed, state-level national analysis; study period not stated |
| S7: diabetes-related readmission rate ratio | 0.97 (FPA versus restricted) | Observed; most FPA-by-post coefficients not significant |
| S8: 30-day readmission, full authority with transition | Odds ratio 0.91 versus restricted practice | Observed, Medicare beneficiaries; study period not stated |
| S8: in-hospital mortality, full authority without transition | Odds ratio 1.11 versus restricted practice | Observed, Medicare beneficiaries; study period not stated |
Case examples are limited to the cited studies and organizations because the pack names no companies.
8Outlook and strategic implications
Base case (near to medium term): NP employment continues to rise, consistent with BLS projections of 474,100 jobs 1 and the 41% growth reported for NPs 2. These are projections, and actual growth depends on education capacity, employer demand and state policy, none of which the pack quantifies.
Alternative case: outcome evidence does not strengthen, and the effects of NP scope remain mixed by care setting 78. In this case, state policy divergence could persist without a clear national evidence base.
Implications for stakeholders: employers and health systems should plan for continued NP demand while tracking transition-of-care outcomes 8. Educators face the projected need of about 32,700 new APRNs a year 4. Policymakers should fund comparable data on cost, waiting times and equity, which the pack shows is missing. Researchers should report study periods, which several cited studies omit 678.
Outlook reflects evidence in the pack and is not a forecast beyond it.
Assumptions behind these figures
- Scenarios are interpretive and are based only on the cited projections and studies.
9Conclusion
Advanced practice nursing in the United States is growing quickly, supported by strong BLS projections 12 and a 38.5% rise in NP numbers 3. Evidence that FPA improves access is encouraging but mixed on outcomes 678. The most defensible takeaway is that workforce growth is well evidenced, while cost, quality and equity claims need better comparative data.
How this was built
This report uses only the source pack. Workforce figures are official statistics and forecasts. Outcome figures come from peer-reviewed state-level studies with stated limits. No market size, company share, reimbursement rate or digital health adoption figure is included because the pack does not verify them. Forecasts are labeled as forecasts and interpretations are labeled as such.
Limits to keep in mind
- No comparable public, private and community provider cost, quality or waiting-time data for NP-led care was found in the pack.
- No verified NP reimbursement rate or payer-level cost data was retrieved, so affordability is not quantified.
- No verified NP-specific digital health adoption data (telehealth or AI tools) was retrieved.
- Equity data by race, rurality or income for NP access was not verified beyond the HRSA nonmetro RN shortage projection.
- The latest available BLS practice setting split is the most recent retrieved. Current setting data were not verified.
- Global advanced practice nursing data outside the United States, including NP or APRN stock and regulation, was not retrieved.
Sources
-
1
Nurse Anesthetists, Nurse Midwives, and Nurse Practitioners
bls.gov -
2
Nurse Practitioners projection release coverage (BLS projection data)
foxbusiness.com -
3
State of US Health Care Workforce
bhw.hrsa.gov -
4
Nursing Shortage Fact Sheet
aacnnursing.org -
5
Job Trends for Nurse Practitioners: BLS practice settings
academicpartnerships.uta.edu -
6
Full practice authority and NP outcomes: difference-in-difference analysis (national)
pubmed.ncbi.nlm.nih.gov -
7
The Impact of Nurse Practitioner Full Practice Authority on Chronic Condition-Related Readmissions and Emergency Department Visits in the United States
pmc.ncbi.nlm.nih.gov -
8
Variation in Patient Outcomes Across Nurse Practitioner Scope of Practice Levels
ncbi.nlm.nih.gov -
9
State of the World's Nursing
who.int -
10
Recover to Rebuild: Investing in the Nursing Workforce for Health System Effectiveness
icn.ch